Search clinical trials for: Alogliptin and glyburide

Total 270174 results

Assistance Publique - Hôpitaux de Paris

Recruiting

Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP) (GALOP)

Preterm | Transient; Hypoglycemia, Neonatal | Glibenclamide Adverse Reaction

France
University of Campinas, Brazil
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects

Hypertension | Obesity | Diabetes Mellitus, Type 2 | Blood Pressure | Vascular Stiffness | Cardiac Hypertrophy | Microalbuminuria

Brazil
Dr. José Fernando Vilela-Martin MD PhD
Novartis

Completed

Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension

Hypertension | Type 2 Diabetes Mellitus | Endothelial Dysfunction

Brazil
Takeda

Completed

Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus (TRINITY)

Type 2 Diabetes Mellitus

Japan
Takeda

Completed

Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants

Pharmacokinetics and Pharmacodynamics

Korea, Republic of
Takeda

Completed

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Poland, Germany, Argentina, South Africa, Netherlands, Peru, Czech Republic, Brazil, Chile, Guatemala, Dominican Republic
Takeda

Completed

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome (EXAMINE)

Diabetes Mellitus, Type 2 | Acute Coronary Syndrome

United States, France, Italy, Poland, Ukraine, United Kingdom, Belgium, Germany, Hong Kong, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, Malaysia, Romania, Serbia, South Africa, Japan, Canada, Finland, Taiwan, Korea,... and more
Takeda

Completed

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Diabetes Mellitus

United States, Poland, Ukraine, Israel, Mexico, Romania, South Africa, Peru, Russian Federation, Hungary, India
Takeda

Completed

Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Poland, Ukraine, Argentina, Israel, Mexico, Romania, Serbia, Australia, Brazil, New Zealand, Russian Federation, Chile, Hungary, Bulgaria, Lithuania, India, Latvia, Croatia, Slovakia, Guatemala, South Africa, Estonia
University of Zambia
University Teaching Hospital, Lusaka, Zambia

Not yet recruiting

Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients (VMGMProtocol)

Diabetes Mellitus Type 2 Without Complication
Takeda

Completed

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Clinical Pharmacology

Japan
Takeda

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution

Japan
Takeda

Completed

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
Azienda Ospedaliero-Universitaria di Parma

Completed

Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes

Type 2 Diabetes

Italy
JW Pharmaceutical

Active, not recruiting

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM (SSUG)

Type 2 Diabetes Mellitus

Korea, Republic of
Takeda

Withdrawn

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Takeda

Completed

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Diabetes Mellitus
Takeda

Completed

Phase 1 Bioavailability Study of SYR-322MET

Healthy Volunteers
Takeda

Completed

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States
Aichi Gakuin University

Unknown

Effects of Alogliptin on Pancreatic Beta Cell Function

Diabetes Mellitus, Type 2

Japan
Danish Headache Center

Completed

The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers

Pain | Migraine | Headache

Denmark
Merck Sharp & Dohme LLC

Completed

Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)

Type 2 Diabetes Mellitus
AstraZeneca

Completed

A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

Diabetes

Korea, Republic of, Mexico, Taiwan, United States, Argentina, Brazil, Puerto Rico, South Africa, Hong Kong, Israel, Singapore, Peru, Philippines
Assaf-Harofeh Medical Center

Unknown

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation

Diabetes Mellitus | Arterial Stiffness

Israel
Takeda

Completed

A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants

Healthy Volunteers

Russian Federation
Takeda

Completed

Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus (ENDURE)

Type 2 Diabetes Mellitus

United States, Poland, Ukraine, United Kingdom, Mexico, Spain, Romania, Israel, Canada, New Zealand, Singapore, Russian Federation, Chile, Puerto Rico, Thailand, Hungary, Austria, Lithuania, Malaysia, Philippines, Australia, India, South... and more
Takeda

Completed

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Takeda

Completed

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan

Diabetes Mellitus, Type 2

Japan
Organon and Co

Completed

Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

Contraception
Nagaoka Red Cross Hospital
Kurume University

Unknown

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Hospital de Clinicas de Porto Alegre

Unknown

Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes (DIABEX-VILDA)

Diabetes Mellitus, Type 2 | Exercise | Hypoglycemic Agents | Diabetic Blood Glucose Monitoring

Brazil
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Type 2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Type2 Diabetes

Korea, Republic of
Ajou University School of Medicine
Dong-A ST Co., Ltd.

Not yet recruiting

Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database

Cerebral Infarction | Dipeptidyl-Peptidase IV Inhibitors | Infarction, Brain
Kaiser Permanente
Patient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaborators

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens (ON TARGET DM)

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United States
Takeda

Completed

Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Takeda

Completed

Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes

Diabetes Mellitus

Japan
Samsung Medical Center

Completed

Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency (DA1229)

Renal Insufficiency | Albuminuria | Type2 Diabetes Mellitus

Korea, Republic of
JW Pharmaceutical

Completed

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone (CWP-DIANA-302)

Type 2 Diabetes Mellitus

Korea, Republic of
Institute of Tropical Medicine, Belgium
University of Liverpool; Rinda Ubuzima

Completed

Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy (Ring-Plus)

Contraception

Rwanda
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects

Healthy Subjects

China
Radboud University Medical Center
Dutch Diabetes Fund

Completed

Ischemic Injury and Ischemic Preconditioning in Diabetes

Diabetes Mellitus, Insulin-Dependent | Ischemia-Reperfusion Injury

Netherlands
Institute for Clinical Effectiveness, Japan

Completed

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial (REASON)

Coronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated Hemoglobin

Japan
Kyunghee University Medical Center
Ministry of Health & Welfare, Korea

Unknown

Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury (AURORAS)

Healthy

Korea, Republic of
Ironwood Pharmaceuticals, Inc.

Completed

Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

Healthy Volunteers

United States
M.D. Anderson Cancer Center

Completed

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Sanofi

Completed

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive (ACADEMIC)

Type 2 Diabetes Mellitus

China
University of Louisville

Completed

Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma (Ewing/Allo)

EWINGS SARCOMA

United States

Search clinical trials for: Alogliptin and glyburide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations